Racial Differences in Postpartum Blood Pressure Trajectories Among Women After a Hypertensive Disorder of Pregnancy

Alisse Hauspurg, Lara Lemon, Camila Cabrera, Amal Javaid, Anna Binstock, Beth Quinn, Jacob Larkin, Andrew R Watson, Richard H Beigi, Hyagriv Simhan, Alisse Hauspurg, Lara Lemon, Camila Cabrera, Amal Javaid, Anna Binstock, Beth Quinn, Jacob Larkin, Andrew R Watson, Richard H Beigi, Hyagriv Simhan

Abstract

Importance: Maternal morbidity and mortality are increasing in the United States, most of which occur post partum, with significant racial disparities, particularly associated with hypertensive disorders of pregnancy. Blood pressure trajectory after a hypertensive disorder of pregnancy has not been previously described.

Objectives: To describe the blood pressure trajectory in the first 6 weeks post partum after a hypertensive disorder of pregnancy and to evaluate whether blood pressure trajectories differ by self-reported race.

Design, setting, and participants: This prospective cohort study included deliveries between January 1, 2018, and December 31, 2019. Women with a clinical diagnosis of a hypertensive disorder of pregnancy were enrolled in a postpartum remote blood pressure monitoring program at the time of delivery and were followed up for 6 weeks. Statistical analysis was performed from April 6 to 17, 2020.

Main outcomes and measures: Mixed-effects regression models were used to display blood pressure trajectories in the first 6 weeks post partum.

Results: A total of 1077 women were included (mean [SD] age, 30.2 [5.6] years; 804 of 1017 White [79.1%] and 213 of 1017 Black [20.9%]). Systolic and diastolic blood pressures were found to decrease rapidly in the first 3 weeks post partum, with subsequent stabilization (at 6 days post partum: mean [SD] peak systolic blood pressure, 146 [13] mm Hg; mean [SD] peak diastolic blood pressure, 95 [10] mm Hg; and at 3 weeks post partum: mean [SD] peak systolic blood pressure, 130 [12] mm Hg; mean [SD] peak diastolic blood pressure, 85 [9] mm Hg). A significant difference was seen in blood pressure trajectory by race, with both systolic and diastolic blood pressure decreasing more slowly among Black women compared with White women (mean [SD] peak systolic blood pressure at 1 week post partum: White women, 143 [14] mm Hg vs Black women, 146 [13] mm Hg; P = .01; mean [SD] peak diastolic blood pressure at 1 week post partum: White women, 92 [9] mm Hg vs Black women, 94 [9] mm Hg; P = .02; and mean [SD] peak systolic blood pressure at 3 weeks post partum: White women, 129 [11] mm Hg vs Black women, 136 [15] mm Hg; P < .001; mean [SD] peak diastolic blood pressure at 3 weeks post partum: White women, 84 [8] mm Hg vs Black women, 91 [13] mm Hg; P < .001). At the conclusion of the program, 126 of 185 Black women (68.1%) compared with 393 of 764 White women (51.4%) met the criteria for stage 1 or stage 2 hypertension (P < .001).

Conclusions and relevance: This study found that, in the postpartum period, blood pressure decreased rapidly in the first 3 weeks and subsequently stabilized. The study also found that, compared with White women, Black women had a less rapid decrease in blood pressure, resulting in higher blood pressure by the end of a 6-week program. Given the number of women with persistent hypertension at the conclusion of the program, these findings also appear to support the importance of ongoing postpartum care beyond the first 6 weeks after delivery.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Hauspurg reported receiving grants from the University of Pittsburgh during the conduct of the study. Dr Simhan reported being a co-founder of Naima Health LLC, which does work in the domain of digital patient engagement, outside the submitted work. No other disclosures were reported.

Figures

Figure 1.. Fitted Blood Pressure (BP) Trajectory…
Figure 1.. Fitted Blood Pressure (BP) Trajectory in First 6 Weeks Post Partum
Shaded area indicates 95% CI.
Figure 2.. Fitted Blood Pressure (BP) Trajectory…
Figure 2.. Fitted Blood Pressure (BP) Trajectory in First 6 Weeks Post Partum by Race
Shaded area indicates 95% CI.

References

    1. Hoyert DL, Miniño AM. Maternal mortality in the United States: changes in coding, publication and data release, 2018. Natl Vital Stat Rep. 2020;69(2):1-18.
    1. Centers for Disease Control and Prevention. Data on selected pregnancy complications in the United States. Published February 28, 2019. Accessed February 10, 2020.
    1. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12. doi:10.1016/j.ajog.2013.08.019
    1. Johnson JD, Louis JM. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? an expert review of the literature. Am J Obstet Gynecol. Published onlinne July 24, 2020. doi:10.1016/j.ajog.2020.07.038
    1. Clapp MA, Little SE, Zheng J, Robinson JN. A multi-state analysis of postpartum readmissions in the United States. Am J Obstet Gynecol. 2016;215(1):113.e1-113.e10. doi:10.1016/j.ajog.2016.01.174
    1. ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1-e25. doi:10.1097/AOG.0000000000003018
    1. ACOG committee opinion no. 736: optimizing postpartum care. Obstet Gynecol. 2018;131(5):e140-e150. doi:10.1097/AOG.0000000000002633
    1. Cairns AE, Pealing L, Duffy JMN, et al. . Postpartum management of hypertensive disorders of pregnancy: a systematic review. BMJ Open. 2017;7(11):e018696. doi:10.1136/bmjopen-2017-018696
    1. Hirshberg A, Downes K, Srinivas S. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf. 2018;27(11):871-877. doi:10.1136/bmjqs-2018-007837
    1. Hauspurg A, Lemon LS, Quinn BA, et al. . A postpartum remote hypertension monitoring protocol implemented at a hospital level. Obstet Gynecol. 2019;134(4):685-691. doi:10.1097/AOG.0000000000003479
    1. Walters BNJ, Walters T. Hypertension in the puerperium. Lancet. 1987;2(8554):330. doi:10.1016/S0140-6736(87)90912-3
    1. Walters BN, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci (Lond). 1986;71(5):589-594. doi:10.1042/cs0710589
    1. Lopes Perdigao J, Hirshberg A, Koelper N, Srinivas SK, Sammel MD, Levine LD. Postpartum blood pressure trends are impacted by race and BMI. Pregnancy Hypertens. 2020;20:14-18. doi:10.1016/j.preghy.2020.02.006
    1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy . Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-1131.
    1. Colin Bell A, Adair LS, Popkin BM. Ethnic differences in the association between body mass index and hypertension. Am J Epidemiol. 2002;155(4):346-353. doi:10.1093/aje/155.4.346
    1. Goland S, Modi K, Hatamizadeh P, Elkayam U. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail. 2013;19(4):214-218. doi:10.1016/j.cardfail.2013.03.004
    1. Irizarry OC, Levine LD, Lewey J, et al. . Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non–African American women. JAMA Cardiol. 2017;2(11):1256-1260. doi:10.1001/jamacardio.2017.3574
    1. Gammill HS, Chettier R, Brewer A, et al. . Cardiomyopathy and preeclampsia. Circulation. 2018;138(21):2359-2366. doi:10.1161/CIRCULATIONAHA.117.031527
    1. Parikh P, Blauwet L. Peripartum cardiomyopathy and preeclampsia: overlapping diseases of pregnancy. Curr Hypertens Rep. 2018;20(8):69. doi:10.1007/s11906-018-0868-9
    1. Taylor RN, Roberts JM, Cunningham FG, Lindheimer MD. Chesley’s Hypertensive Disorders in Pregnancy. 4th ed Elsevier; 2015.
    1. Perdigao JL, Lewey J, Hirshberg A, et al. . LB 4: furosemide for accelerated recovery of blood pressure postpartum: a randomized placebo controlled trial (FoR BP). Am J Obstet Gynecol. 2020;222(1):S759-S760. doi:10.1016/j.ajog.2019.11.1278
    1. Hoppe KK, Williams M, Thomas N, et al. . Telehealth with remote blood pressure monitoring for postpartum hypertension: a prospective single-cohort feasibility study. Pregnancy Hypertens. 2019;15:171-176. doi:10.1016/j.preghy.2018.12.007
    1. Levine LD, Nkonde-Price C, Limaye M, Srinivas SK. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol. 2016;36(12):1079-1082. doi:10.1038/jp.2016.137
    1. Graves CR, Davis SF. Cardiovascular complications in pregnancy: it is time for action. Circulation. 2018;137(12):1213-1215. doi:10.1161/CIRCULATIONAHA.117.031592
    1. Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension. 2012;60(6):1368-1373. doi:10.1161/HYPERTENSIONAHA.112.198812
    1. Hauspurg A, Ying W, Hubel CA, Michos ED, Ouyang P. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol. 2018;41(2):239-246. doi:10.1002/clc.22887
    1. Haas DM, Parker CB, Marsh DJ, et al. ; NHLBI nuMoM2b Heart Health Study . Association of adverse pregnancy outcomes with hypertension 2 to 7 years postpartum. J Am Heart Assoc. 2019;8(19):e013092. doi:10.1161/JAHA.119.013092
    1. Pew Research Center. Mobile fact sheet. Published June 12, 2019. Accessed April 6, 2020.
    1. Whelton PK, Carey RM, Aronow WS, et al. . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115. doi:10.1161/HYP.0000000000000065
    1. Leenen FHH, Nwachuku CE, Black HR, et al. ; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group . Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006;48(3):374-384. doi:10.1161/
    1. Tedla YG, Schwartz SM, Silberman P, Greenland P, Passman RS. Racial disparity in the prescription of anticoagulants and risk of stroke and bleeding in atrial fibrillation patients. J Stroke Cerebrovasc Dis. 2020;29(5):104718. doi:10.1016/j.jstrokecerebrovasdis.2020.104718
    1. Berhie SH, Riley LE, Bryant AS. Disparities in 17-hydroxyprogesterone caproate offer and uptake in pregnancies at a risk of preterm birth. Am J Perinatol. 2019;36(10):1066-1071. doi:10.1055/s-0038-1676113
    1. Yee LM, Liu LY, Sakowicz A, Bolden JR, Miller ES. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth. Am J Obstet Gynecol. 2016;214(3):374.e1-374.e6. doi:10.1016/j.ajog.2015.12.054

Source: PubMed

3
Iratkozz fel